RecruitingPhase 4NCT05550194

VZV in the Enteric Nervous System: Pathogenesis and Consequences

Studying Idiopathic achalasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Vanderbilt University Medical Center
Principal Investigator
Michael Vaezi, MD
Vanderbilt University Medical Center
Intervention
ValACYclovir 1000 MG(drug)
Enrollment
40 target
Eligibility
18-75 years · All sexes
Timeline
20232026

Study locations (1)

Collaborators

Columbia University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05550194 on ClinicalTrials.gov

Other trials for Idiopathic achalasia

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic achalasia

← Back to all trials